canada clinical guidance

Childhood immunization schedule

A Canadian clinical summary of childhood immunization schedule, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This summary is bounded to the recommendations, population and decisions covered by Recommended immunization schedules: Canadian Immunization Guide. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:NACI schedules

Source-attributed clinical priorities

  • Use the province or territory鈥檚 current publicly funded schedule; Canada does not have one operational schedule used identically everywhere.
  • Apply NACI recommendations to indications, contraindications, special populations and minimum intervals.
  • Use catch-up principles without restarting a valid series and document product, lot, route, site and adverse-event advice.
  • The child鈥檚 province or territory determines the routine product and schedule even though national recommendations inform it.
sources for this section:NACI schedules

Practical assessment and management workflow

1
Reconstruct prior doses from records and identify age, health conditions, travel and exposure risks.
2
Use the current jurisdictional catch-up table without restarting a valid series unnecessarily.
3
Screen true contraindications, counsel on expected reactions and administer indicated vaccines at the same visit.
4
Document product, lot, site and date in the appropriate record and schedule remaining doses.
sources for this section:NACI schedules

Safety, red flags and urgent escalation

  • Anaphylaxis after a previous dose or component requires specialist vaccination assessment.
  • Acute minor illness is not usually a reason to miss vaccination.
  • Report serious adverse events through the provincial or territorial vaccine-safety pathway.
sources for this section:NACI schedules

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:NACI schedules

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:NACI schedules

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.